McMillion Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.29M | Sell |
10,123
-500
| -5% | -$65K | 1.14% | 32 |
|
|
2023
Q1 | $1.37M | Sell |
10,623
-803
| -7% | -$105K | 1.29% | 27 |
|
|
2022
Q4 | $1.5M | Sell |
11,426
-290
| -2% | -$37.5K | 1.36% | 28 |
|
|
2022
Q3 | $1.37M | Sell |
11,716
-567
| -5% | -$70.4K | 1.27% | 29 |
|
|
2022
Q2 | $1.45M | Sell |
12,283
-2,959
| -19% | -$351K | 1.2% | 31 |
|
|
2022
Q1 | $1.99M | Sell |
15,242
-1,992
| -12% | -$259K | 1.23% | 32 |
|
|
2021
Q4 | $2.63M | Sell |
17,234
-139
| -0.8% | -$21.5K | 1.42% | 28 |
|
|
2021
Q3 | $2.81M | Sell |
17,373
-2,870
| -14% | -$483K | 1.65% | 20 |
|
|
2021
Q2 | $3.31M | Sell |
20,243
-2,675
| -12% | -$412K | 1.81% | 16 |
|
|
2021
Q1 | $3.45M | Buy |
22,918
+803
| +4% | +$128K | 2.02% | 16 |
|
|
2020
Q4 | $3.35M | Buy |
22,115
+86
| +0.4% | +$12.3K | 2.04% | 13 |
|
|
2020
Q3 | $2.98M | Sell |
22,029
-791
| -3% | -$107K | 2.24% | 13 |
|
|
2020
Q2 | $3.12M | Sell |
22,820
-756
| -3% | -$96.4K | 2.05% | 13 |
|
|
2020
Q1 | $2.54M | Sell |
23,576
-93
| -0.4% | -$10.7K | 1.73% | 21 |
|
|
2019
Q4 | $2.85M | Sell |
23,669
-96
| -0.4% | -$10.7K | 1.37% | 36 |
|
|
2019
Q3 | $2.37M | Sell |
23,765
-1,733
| -7% | -$181K | 1.26% | 38 |
|
|
2019
Q2 | $2.78M | Buy |
25,498
+14
| +0.1% | +$1.49K | 1.47% | 32 |
|
|
2019
Q1 | $2.85M | Buy |
25,484
+972
| +4% | +$107K | 1.54% | 29 |
|
|
2018
Q4 | $2.36M | Buy |
24,512
+976
| +4% | +$104K | 1.53% | 31 |
|
|
2018
Q3 | $2.87M | Buy |
23,536
+732
| +3% | +$86.2K | 1.53% | 32 |
|
|
2018
Q2 | $2.5M | Buy |
22,804
+787
| +4% | +$84.2K | 1.42% | 36 |
|
|
2018
Q1 | $2.35M | Buy |
22,017
+405
| +2% | +$44.9K | 1.39% | 36 |
|
|
2017
Q4 | $2.31M | Buy |
21,612
+1,122
| +5% | +$120K | 1.39% | 38 |
|
|
2017
Q3 | $2.28M | Sell |
20,490
-579
| -3% | -$61.9K | 1.5% | 33 |
|
|
2017
Q2 | $2.18M | Buy |
21,069
+231
| +1% | +$22.8K | 1.46% | 33 |
|
|
2017
Q1 | $2.04M | Buy |
20,838
+210
| +1% | +$20.1K | 1.39% | 34 |
|
|
2016
Q4 | $1.82M | Sell |
20,628
-39
| -0.2% | -$3.55K | 1.3% | 36 |
|
|
2016
Q3 | $1.99M | Buy |
20,667
+705
| +4% | +$67.1K | 1.49% | 33 |
|
|
2016
Q2 | $1.71M | Sell |
19,962
-3,885
| -16% | -$349K | 1.32% | 38 |
|
|
2016
Q1 | $2.07M | Buy |
23,847
+297
| +1% | +$26.6K | 1.54% | 34 |
|
|
2015
Q4 | $2.66M | Sell |
23,550
-498
| -2% | -$54.1K | 1.99% | 26 |
|
|
2015
Q3 | $2.43M | Sell |
24,048
-2,475
| -9% | -$297K | 1.88% | 29 |
|
|
2015
Q2 | $3.26M | Sell |
26,523
-1,575
| -6% | -$189K | 2.03% | 23 |
|
|
2015
Q1 | $3.22M | Buy |
+28,098
| New | +$3.1M | 1.92% | 27 |
|
Other funds holding IBB
CB
McMillion Capital Management's IBB Position: Q2 2023 in Review
McMillion Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 4.7% in Q2 2023, selling an estimated $65K and leaving 10,123 shares worth $1.29M. The position accounts for 1.14% of the portfolio, ranked #32.
McMillion Capital Management first reported a position in IBB in Q1 2015 and has held it in 34 quarters since. The position peaked at $3.45M in Q1 2021. 844 funds tracked by Wall St. Rank hold IBB as of Q2 2023.
- McMillion Capital Management held 10,123 shares of iShares Biotechnology ETF worth $1.29M as of Q2 2023.
- McMillion Capital Management sold 500 iShares Biotechnology ETF shares in Q2 2023, an estimated $65K.
- iShares Biotechnology ETF made up 1.14% of McMillion Capital Management's portfolio in Q2 2023, its #32 holding.
- McMillion Capital Management first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 34 quarters since.
- McMillion Capital Management's iShares Biotechnology ETF position peaked at $3.45M in Q1 2021.
- 844 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.
Based on McMillion Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.